Share
Back to All Resources
Buprenorphine/Naloxone (Suboxone) for Opioid Use Disorder: Your Questions Answered
Posted October 29, 2021
CPSA’s website will be temporarily unavailable due to scheduled IT maintenance on Thursday, Feb. 6 from 7 to 10 p.m.
- Albertans
Physician DirectoryContact & practice info for Alberta physicians
ComplaintsFile a complaint about an Alberta physician
Patient SafetyResources & info for Albertans
Discipline DecisionsWe post decisions as they are available
Albertan FAQsFrequently asked questions and responses
ConversationsShare your healthcare experiences
- Physicians
RegistrationApply to practice & learn about assessments- ComplaintsInfo about complaints, hearings & appeals
CompetenceTools & support for physician competence
PrescribingPrescribing resources & TPP Alberta info
Physician HealthConfidential & collaborative support
Standards of PracticeExpectations of physician professionalism
COVID-19 Info for PhysiciansGuidance & resources for physicians
- Facilities & Clinics
- Physician Assistants
- About CPSA
GovernanceInfo about our Council, committees and governance policies
Equity in Health CareOur commitment to safe and equitable care
ResearchEvidence-based medical regulation
OpportunitiesCareer and contract opportunities
Corporate ServicesFee schedules and other operations resources
MessengerOur monthly newsletter
Grants & AwardsRecognizing and supporting our community
Contact UsWays to reach us, plus info for media
-
- Registration
- Complaints
- Competence
- Prescribing
- Physician Health
- Standards of Practice
- COVID-19 Info for Physicians